About the Company
personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PSNL News
Personalis, Inc. (PSNL) Latest Stock News & Headlines - Yahoo Finance
Personalis, Inc. (NASDAQ:PSNL) Q4 2023 Earnings Call Transcript February 28, 2024 Personalis, Inc. misses on earnings expectations. Reported EPS is $-0.54 EPS, expectations were $-0.53.
Personalis: Q4 Earnings Snapshot
FREMONT, Calif. (AP) — FREMONT, Calif. (AP) — Personalis Inc. (PSNL) on Wednesday reported a loss of $26.6 million in its fourth quarter. On a per-share basis, the Fremont, California-based ...
Personalis, Inc. (PSNL) Interactive Stock Chart - Yahoo Finance
Personalis, Inc. (NASDAQ:PSNL) Q4 2023 Earnings Call Transcript February 28, 2024 Personalis, Inc. misses on earnings expectations. Reported EPS is $-0.54 EPS, expectations were $-0.53.
Personalis, Inc. (PSNL) Q4 2023 Earnings Call Transcript
Greetings, and welcome to the Personalis Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. Brief question-and-answer session will follow the ...
Personalis, Inc. (04X.F)
Personalis, Inc. ( NASDAQ:PSNL ) shares have had a really impressive month, gaining 37% after a shaky period... Personalis, Inc. (NASDAQ:PSNL) Q3 2023 Earnings Call Transcript November 7, 2023 ...
Loading the latest forecasts...